Cargando…
Outside in – inside out. Creating focus on the patient – a vaccine company perspective
Involving patients in the development of medicines and vaccines should result in benefits to patients. The vaccine recipient is usually a healthy person. We describe the rationale and implementation of a vaccine company's initiative to encourage employees to identify with patients of the condit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037448/ https://www.ncbi.nlm.nih.gov/pubmed/29341845 http://dx.doi.org/10.1080/21645515.2018.1428510 |
_version_ | 1783338331073937408 |
---|---|
author | Sohy, Denis Dusart, Isabelle Goulet, Philibert Visy, Diane Gasthuys, Luc Poplazarova, Tatjana Breuer, Thomas Begg, Norman |
author_facet | Sohy, Denis Dusart, Isabelle Goulet, Philibert Visy, Diane Gasthuys, Luc Poplazarova, Tatjana Breuer, Thomas Begg, Norman |
author_sort | Sohy, Denis |
collection | PubMed |
description | Involving patients in the development of medicines and vaccines should result in benefits to patients. The vaccine recipient is usually a healthy person. We describe the rationale and implementation of a vaccine company's initiative to encourage employees to identify with patients of the conditions prevented by the vaccines they help to produce. The Voice of the Patient (“VoP”), begun in 2014, is an educational programme directed at the 16,000 employees of a global vaccine company. It engages employees through an understanding that they are all “vaccine patients”, and that they can make a difference by considering the impact of decisions made in their day to day work. The initiative includes presentations about vaccine-preventable diseases, global live webcasts with experts and patients, employee visits to healthcare facilities in developing countries, and the production of patient-focused sections in research publications. In a 2017 employee survey, 90% of respondents said they know how their daily work impacts patients and they demonstrate focus on patients. We believe this is preliminary evidence that, by supporting employee awareness of the impact of their individual roles, VoP could be a model for a type of initiative that will contribute to industry's continuing evolution towards more patient-centred healthcare. |
format | Online Article Text |
id | pubmed-6037448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-60374482018-07-11 Outside in – inside out. Creating focus on the patient – a vaccine company perspective Sohy, Denis Dusart, Isabelle Goulet, Philibert Visy, Diane Gasthuys, Luc Poplazarova, Tatjana Breuer, Thomas Begg, Norman Hum Vaccin Immunother Commentary Involving patients in the development of medicines and vaccines should result in benefits to patients. The vaccine recipient is usually a healthy person. We describe the rationale and implementation of a vaccine company's initiative to encourage employees to identify with patients of the conditions prevented by the vaccines they help to produce. The Voice of the Patient (“VoP”), begun in 2014, is an educational programme directed at the 16,000 employees of a global vaccine company. It engages employees through an understanding that they are all “vaccine patients”, and that they can make a difference by considering the impact of decisions made in their day to day work. The initiative includes presentations about vaccine-preventable diseases, global live webcasts with experts and patients, employee visits to healthcare facilities in developing countries, and the production of patient-focused sections in research publications. In a 2017 employee survey, 90% of respondents said they know how their daily work impacts patients and they demonstrate focus on patients. We believe this is preliminary evidence that, by supporting employee awareness of the impact of their individual roles, VoP could be a model for a type of initiative that will contribute to industry's continuing evolution towards more patient-centred healthcare. Taylor & Francis 2018-02-15 /pmc/articles/PMC6037448/ /pubmed/29341845 http://dx.doi.org/10.1080/21645515.2018.1428510 Text en © 2018 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Sohy, Denis Dusart, Isabelle Goulet, Philibert Visy, Diane Gasthuys, Luc Poplazarova, Tatjana Breuer, Thomas Begg, Norman Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title | Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title_full | Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title_fullStr | Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title_full_unstemmed | Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title_short | Outside in – inside out. Creating focus on the patient – a vaccine company perspective |
title_sort | outside in – inside out. creating focus on the patient – a vaccine company perspective |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037448/ https://www.ncbi.nlm.nih.gov/pubmed/29341845 http://dx.doi.org/10.1080/21645515.2018.1428510 |
work_keys_str_mv | AT sohydenis outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT dusartisabelle outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT gouletphilibert outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT visydiane outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT gasthuysluc outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT poplazarovatatjana outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT breuerthomas outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective AT beggnorman outsideininsideoutcreatingfocusonthepatientavaccinecompanyperspective |